| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/18/1995 | US5407941 Platelet activating factor antagonist and antihistamine; useful for treating asthma and allergic disorders |
| 04/18/1995 | US5407923 Antiinflammatory agents |
| 04/18/1995 | US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009908A1 Novel tissue plasminogen activator analog |
| 04/13/1995 | WO1995009869A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 04/13/1995 | WO1995009842A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/13/1995 | WO1995009611A2 Stable protein: phospholipid compositions and methods |
| 04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 04/13/1995 | CA2173598A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 04/13/1995 | CA2148361A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/12/1995 | EP0647447A1 Carbostyril derivatives as phosphodiesterase inhibitors |
| 04/12/1995 | EP0647237A1 Double chain peptide compounds having hemoregulatory activity |
| 04/12/1995 | EP0511234B1 Stable injectible solutions for factor viii |
| 04/12/1995 | EP0383764B1 Bovine granulocyte-macrophage colony stimulating factor |
| 04/12/1995 | CN1028173C Oxazole derivatives |
| 04/11/1995 | US5405988 9-substituted bicyclo[3.3.0]octane derivatives, process for their production and their pharmaceutical use |
| 04/11/1995 | US5405857 3-substituted 1,2,3,4,-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds |
| 04/11/1995 | US5405854 Sulfonamidocarboxamides |
| 04/11/1995 | US5405742 Contains purge and maintenance solutions; infusing organ to be transplanted with maintenance solution |
| 04/06/1995 | WO1995009188A1 Antithrombotic |
| 04/06/1995 | WO1995009005A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 04/06/1995 | CA2172808A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 04/05/1995 | EP0646376A1 Immunomodulating and antiinflammatory agent |
| 04/05/1995 | EP0646130A1 Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides. |
| 04/05/1995 | EP0422198B1 Phosphorylated plasminogen activators |
| 04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
| 04/05/1995 | CN1101043A Process for preparing oxazole derivatives |
| 04/05/1995 | CN1101042A Process for preparing oxazole derivatives |
| 04/05/1995 | CN1101041A Process for preparing oxazole derivatives |
| 04/05/1995 | CN1101039A 哌嗪衍生物 Piperazine derivatives |
| 04/04/1995 | US5403836 Anticoagulants |
| 04/04/1995 | US5403827 Process for preparing epoxy-heparides, the products obtained and pharmaceutical compositions containing them |
| 04/04/1995 | US5403734 t-PA with growth factor domain substitutions |
| 04/04/1995 | US5403596 Anticoagulant from saliva of leech; does not inhibit thrombin |
| 04/04/1995 | CA1335075C Method of inhibiting platelet dependent arterial thrombosis |
| 03/30/1995 | WO1995008574A1 Displacement chromatography process and purified hemoglobin product |
| 03/30/1995 | WO1995008573A1 Peptide having antithrombotic activity and process for producing the same |
| 03/30/1995 | WO1995008563A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 03/30/1995 | WO1995008536A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 03/30/1995 | WO1995008532A1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 03/29/1995 | EP0645376A1 Substituted 1-phenyl-oxazolidin-2-one derivatives, their preparation and their use as adhesion-receptor antagonists |
| 03/29/1995 | EP0645142A1 A novel physiologically active substance |
| 03/29/1995 | EP0645138A2 Pharmaceutical composition for maintaining and/or reestablishing a rate of blood platelet aggregation clone to the normal value |
| 03/29/1995 | EP0644762A1 Pyrazolopyridine compounds for the treatment of anemia |
| 03/29/1995 | EP0558563B1 Anti-inflammatory compounds |
| 03/29/1995 | EP0500602B1 Agent for neutralising the procoagulant activity associated with tumor cells |
| 03/29/1995 | EP0332667B1 Vector for integration site independent gene expression in mammalian host cells |
| 03/28/1995 | US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments |
| 03/28/1995 | US5401754 Agent for treating thrombosis and phosphodiesterase inhibitor |
| 03/28/1995 | US5401730 Method for reducing platelet aggregation |
| 03/28/1995 | CA1334942C Production of m-csf |
| 03/24/1995 | CA2132579A1 Adhesion receptor antagonists iii |
| 03/23/1995 | WO1995007986A1 Pharmaceutical compositions containing ecotin and homologs thereof |
| 03/23/1995 | WO1995007932A1 Improvements in or relating to haemoglobin |
| 03/23/1995 | WO1995007713A1 Activated factor viii as a therapeutic agent and method of treating factor viii deficiency |
| 03/23/1995 | WO1995007691A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/23/1995 | WO1995005393A3 Lipopolysaccharide-binding and neutralizing peptides |
| 03/23/1995 | WO1995003333A3 Tryptase inhibitor |
| 03/23/1995 | CA2170638A1 Improvements in or relating to haemoglobin |
| 03/23/1995 | CA2170030A1 Pharmaceutical compositions containing ecotin and homologs thereof |
| 03/23/1995 | CA2168332A1 Activated factor viii as a therapeutic agent and method of treating factor viii deficiency |
| 03/22/1995 | EP0643973A1 Use of human interferon-beta for the preparation of pharmaceutical compositions for treating Chronic Myeloid Leukemia |
| 03/22/1995 | EP0643972A2 Use of recombinant colony stimulating factor-1 for the preparation of a medicament for cytomegalovirus infections and leukopenia |
| 03/22/1995 | EP0643780A1 Multiple solvent cleaning system. |
| 03/22/1995 | EP0643725A1 Single chain peptide compounds having hemoregulatory activity |
| 03/22/1995 | EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
| 03/22/1995 | EP0440763B1 t-PA MUTANT GK1L |
| 03/21/1995 | US5399698 Quinolin-2-yl-methoxybenzylhydroxyureas |
| 03/21/1995 | US5399671 Specifically crosslinked hemoglobin with free functionality |
| 03/21/1995 | US5399570 Aspartic acid derivatives, and their use for inhibiting platelete aggregation |
| 03/21/1995 | US5399550 Physiologically active substance derived or malt and process for the production thereof |
| 03/21/1995 | US5399318 Blood sampling apparatus containing an anticoagulant composition |
| 03/16/1995 | WO1995007364A1 Nucleic acid ligands and improved methods for producing the same |
| 03/16/1995 | DE4432549A1 Pharmaceutical products with antithrombotic activity and process for the production thereof |
| 03/16/1995 | CA2169536A1 Nucleic acid ligands and improved methods for producing the same |
| 03/15/1995 | EP0643073A1 Tripeptide antithrombotic agents |
| 03/15/1995 | EP0642515A1 New ginkgolide derivatives and a process for preparing them |
| 03/15/1995 | EP0642504A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
| 03/15/1995 | EP0642356A1 Antibodies to p-selectin and their uses |
| 03/15/1995 | EP0642352A1 TRUNCATED TISSUE FACTOR AND FVIIa OR FVII ACTIVATOR FOR BLOOD COAGULATION |
| 03/15/1995 | EP0563153B1 N-(mercaptoalkyl)amides |
| 03/15/1995 | EP0535129B1 An anticoagulant preparation |
| 03/15/1995 | EP0433393B1 Treatment of damaged bone marrow and dosage units therefor |
| 03/15/1995 | CA2131977A1 Pharmaceutic composition for maintaining and/or restoring a near normal platelet aggregation rate |
| 03/14/1995 | US5397796 Inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces |
| 03/14/1995 | US5397791 Fibrinogen receptor antagonists |
| 03/14/1995 | US5397703 Method for generation of antibodies to cell surface molecules |
| 03/14/1995 | CA1334754C 5-aryl-substituted-2,3-dihydro-imidazo¬1,2-a|furo and -thieno pyridines |
| 03/14/1995 | CA1334753C Glycerin derivative and its pharmacological use |
| 03/09/1995 | WO1995006645A1 Benzofuran derivatives as tachykinin antagonists |
| 03/09/1995 | WO1995006475A1 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta |
| 03/09/1995 | CA2170979A1 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta |
| 03/08/1995 | EP0641779A1 Novel 1-amidinopiperdines and 4-amidinomorpholines as aggregation inhibitions |
| 03/08/1995 | EP0641359A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 03/08/1995 | EP0641343A1 4-mercaptoacetylamino- 2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
| 03/08/1995 | EP0641327A1 Novel alpha-mannosidase inhibitors |
| 03/08/1995 | EP0641215A1 Protease-resistant thrombomodulin analogs |
| 03/08/1995 | EP0641213A1 Use of exogeneous glycosaminoglycanes or derivatives in the treatment of thrombopenias |